Skip to main content
logo
Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.5408
-0.0052 (-0.95%)
Aug 12, 2026, 2:46 PM EDT - Market open

Mangoceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
0.410.460.620.730.01
Revenue Growth
-18.88%-25.96%-15.81%8083.16%-
Gross Profit
0.220.250.380.430
Operating Income
-16.31-19.15-8.69-9.22-1.99
Net Income
-19.21-20.64-8.71-9.21-2
Earnings Per Share
-1.49-2.17-4.80-8.58-2.85
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
0.171.490.060.740.68
Total Debt
0.290.310.210.130.35
Net Cash (Debt)
-0.121.18-0.160.610.33
Net Cash Growth
---84.95%-
Net Cash Per Share
-0.010.12-0.080.570.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-4.89-5.85-4.86-7-1.35
Capital Expenditures
----0-0.04
Free Cash Flow
-4.89-5.85-4.86-7-1.39
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
52.42%54.91%61.70%58.99%54.26%
Operating Margin
-3933.02%-4200.46%-1411.58%-1260.28%-22279.70%
Pretax Margin
-4632.92%-4526.86%-1413.80%-1259.40%-22352.11%
Profit Margin
-4632.92%-4526.86%-1413.80%-1259.40%-22352.10%
FCF Margin
-1178.74%-1282.89%-789.74%-957.07%-15545.60%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
22.6129.0228.448.10--